Global Eye Drop Market, By Type (Prescription v/s Over-the-Counter), By Drug Class (Anti-allergy, Anti-glaucoma, Anti-inflammatory, Anti-VEGF, and Others), By Disease Indication (Eye Allergy, Glaucoma, Eye Infections, Dry Eye Diseases, and Retinal Disorders), By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, and Online Pharmacy), By Region, Competition Forecast and Opportunities, 2027
Global eye drop market was valued at USD13530 million in 2021 and is anticipated to grow with a CAGR of 6.46% during the forecast period to achieve a market value of USD19758 million by 2027. The market is anticipated to grow on account of increasing instances of eye infection in the population. Higher prevalence of eye diseases like eye dryness, redness, itching in the eyes, conjunctivitis, soreness, glaucoma, etc. further drive the growth of the global eye drop market in the upcoming five years. Excessive screen time and penetration of smart phones, laptops, television, and electronics further supports the growth of the global eye drop market in the next five years. The governments around the world are actively investing in the healthcare industry and increasing the production of the pharmaceuticals and therapeutics products in the recent years. Growing imports & exports of the pharmaceutical & therapeutics products like eye drops further aid the growth of the global eye drop market in the future five years. Also, the consumers in the country have been spending over healthcare services to attain excellent patient care. Rising disposable income of the population also sustains the market growth. Technological advancement in product manufacturing, expanding logistics sector with easy distribution of the products further aids the growth of the global eye drop market in the forecast period.
The global eye drop market is segmented by type, drug class, disease indication, distribution channel, competitional landscape, and regional distribution. Based on type, the market is further differentiated into prescription and over the counter. Prescription type eye drops are anticipated to hold the largest revenue shares of the market and dominate the market segment in the upcoming five years on account of increasing instances of eye diseases. Increasing instances of diabetes and thus higher risks of catching eye diseases, vision impairment, also aids to the growth of the segment. Over the counter eye drops are expected to achieve the fastest growth owing to increasing tendency of the consumers to self-medicate their conditions of eye burning sensations and redness, etc. Increasing common eye itchiness and dryness due to prolonged screen times also aid to the growth of the sub-segment along with the growth of the global eye drops market in the future five years.
Johnson & Johnson Inc, Genentech, Inc. (Roche), Alcon Inc., Pfizer, Inc., Bausch Health Companies, Inc., Bayer Corporation, Allergan, Inc. (AbbVie), Abbott Laboratories, Inc., KC Pharmaceuticals, Inc., Akorn, Inc. are among the major market players in the global eye drop market.
Years considered for this report:
Historical Years: 2017- 2020
Base Year: 2021
Estimated Year: 2022E
Forecast Period: 2023F – 2027F
Objective of the Study:
- To analyze the historical growth in the market size of global eye drop market from 2017 to 2021.
- To estimate and forecast the market size of global eye drop market from 2022E to 2027F and growth rate until 2027F.
- To classify and forecast global eye drop market based on type, drug class, disease indication, distribution channel, competitional landscape, and regional distribution.
- To identify dominant region or segment in the global eye drop market.
- To identify drivers and challenges for global eye drop market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global eye drop market.
- To identify and analyze the profile of leading players operating in global eye drop market.
- To identify key sustainable strategies adopted by market players in global eye drop market.
TechSci Research calculated the market size of global eye drop market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these products and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
- Eye drops manufacturers and suppliers
- Distributors and other stakeholders
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to eye drops
- Market research and consulting firms
Report Scope:
In this report, global eye drop market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Eye Drop Market, By Type:
- Prescription
- Over-The-Counter
- Eye Drop Market, By Drug Class:
- Anti-allergy
- Anti-glaucoma
- Anti-inflammatory
- Anti-VEGF
- Others
- Eye Drop Market, By Disease Indication:
- Eye Allergy
- Glaucoma
- Eye Infections
- Dry Eye Diseases
- Retinal Disorders
- Eye Drop Market, By Distribution Channel:
- Hospitals Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Eye Drop Market, By Region:
- North America
Canada
Mexico
- Europe
United Kingdom
Germany
France
Spain
Italy
- Asia-Pacific
India
Japan
Australia
South Korea
Indonesia
- South America
Argentina
Colombia
- Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global eye drop marketThe following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1.Johnson & Johnson Inc.
2.Genentech, Inc. (Roche)
3.Alcon Inc.
4.Pfizer, Inc.
5.Bausch Health Companies, Inc.
6.Bayer Corporation
7.Allergan, Inc. (AbbVie)
8.Abbott Laboratories Inc.
9.KC Pharmaceuticals, Inc.
10.Akorn, Inc.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order. Single User license will be delivered in PDF format without printing rights
- 1. Product Overview
- 2. Research Methodology
- 3. Executive Summary
- 4. Impact of COVID-19 on Global Eye Drop Market
- 5. Voice of Customer
- 5.1. Brand Awareness
- 5.2. Factors Contributing to demand for Eye Drops
- 5.3. Demand, By Drug Class
- 5.4. Demand, By Disease Indication
- 5.5. Preference, By Distribution Channel
- 6. Global Eye Drop Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Type (Prescription v/s Over-The-Counter)
- 6.2.2. By Drug Class (Antiallergy, Anti-inflammatory, Antiglaucoma, Anti-VEGF, Others)
- 6.2.3. By Disease Indication (Dry Eye Diseases, Glaucoma, Eye Allergy, Eye Infections, Retinal Disorders, Others)
- 6.2.4. By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy)
- 6.2.5. By Region
- 6.2.6. By Company (2021)
- 6.3. Product Market Map
- 7. North America Eye Drop Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Drug Class
- 7.2.3. By Disease Indication
- 7.2.4. By Distribution Channel
- 7.2.5. By Country
- 7.3. North America: Country Analysis
- 7.3.1. United States Eye Drop Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Type
- 7.3.1.2.2. By Drug Class
- 7.3.1.2.3. By Disease Indication
- 7.3.1.2.4. By Distribution Channel
- 7.3.2. Canada Eye Drop Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Type
- 7.3.2.2.2. By Drug Class
- 7.3.2.2.3. By Disease Indication
- 7.3.2.2.4. By Distribution Channel
- 7.3.3. Mexico Eye Drop Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Type
- 7.3.3.2.2. By Drug Class
- 7.3.3.2.3. By Disease Indication
- 7.3.3.2.4. By Distribution Channel
- 8. Europe Eye Drop Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Drug Class
- 8.2.3. By Disease Indication
- 8.2.4. By Country
- 8.3. Europe: Country Analysis
- 8.3.1. Russia Federation Eye Drop Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Type
- 8.3.1.2.2. By Drug Class
- 8.3.1.2.3. By Disease Indication
- 8.3.1.2.4. By Distribution Channel
- 8.3.2. United Kingdom Eye Drop Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Type
- 8.3.2.2.2. By Drug Class
- 8.3.2.2.3. By Disease Indication
- 8.3.2.2.4. By Distribution Channel
- 8.3.3. Germany Eye Drop Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Type
- 8.3.3.2.2. By Drug Class
- 8.3.3.2.3. By Disease Indication
- 8.3.3.2.4. By Distribution Channel
- 8.3.4. France Eye Drop Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Type
- 8.3.4.2.2. By Drug Class
- 8.3.4.2.3. By Disease Indication
- 8.3.4.2.4. By Distribution Channel
- 8.3.5. Spain Eye Drop Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Type
- 8.3.5.2.2. By Drug Class
- 8.3.5.2.3. By Disease Indication
- 8.3.5.2.4. By Distribution Channel
- 8.3.6. Italy Eye Drop Market Outlook
- 8.3.6.1. Market Size & Forecast
- 8.3.6.1.1. By Value
- 8.3.6.2. Market Share & Forecast
- 8.3.6.2.1. By Type
- 8.3.6.2.2. By Drug Class
- 8.3.6.2.3. By Disease Indication
- 8.3.6.2.4. By Distribution Channel
- 9. Asia-Pacific Eye Drop Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Drug Class
- 9.2.3. By Disease Indication
- 9.2.4. By Distribution Channel
- 9.2.5. By Country
- 9.3. Asia-Pacific: Country Analysis
- 9.3.1. China Eye Drop Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Type
- 9.3.1.2.2. By Drug Class
- 9.3.1.2.3. By Disease Indication
- 9.3.1.2.4. By Distribution Channel
- 9.3.2. India Eye Drop Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Type
- 9.3.2.2.2. By Drug Class
- 9.3.2.2.3. By Disease Indication
- 9.3.2.2.4. By Distribution Channel
- 9.3.3. Japan Eye Drop Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Type
- 9.3.3.2.2. By Drug Class
- 9.3.3.2.3. By Disease Indication
- 9.3.3.2.4. By Distribution Channel
- 9.3.4. Australia Eye Drop Market Outlook
- 9.3.4.1. Market Size & Forecast
- 9.3.4.1.1. By Value
- 9.3.4.2. Market Share & Forecast
- 9.3.4.2.1. By Type
- 9.3.4.2.2. By Drug Class
- 9.3.4.2.3. By Disease Indication
- 9.3.4.2.4. By Distribution Channel
- 9.3.5. South Korea Eye Drop Market Outlook
- 9.3.5.1. Market Size & Forecast
- 9.3.5.1.1. By Value
- 9.3.5.2. Market Share & Forecast
- 9.3.5.2.1. By Type
- 9.3.5.2.2. By Drug Class
- 9.3.5.2.3. By Disease Indication
- 9.3.5.2.4. By Distribution Channel
- 9.3.6. Indonesia Eye Drop Market Outlook
- 9.3.6.1. Market Size & Forecast
- 9.3.6.1.1. By Value
- 9.3.6.2. Market Share & Forecast
- 9.3.6.2.1. By Type
- 9.3.6.2.2. By Drug Class
- 9.3.6.2.3. By Disease Indication
- 9.3.6.2.4. By Distribution Channel
- 10. South America Eye Drop Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Drug Class
- 10.2.3. By Disease Indication
- 10.2.4. By Distribution Channel
- 10.2.5. By Country
- 10.3. South America: Country Analysis
- 10.3.1. Brazil Eye Drop Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Type
- 10.3.1.2.2. By Drug Class
- 10.3.1.2.3. By Disease Indication
- 10.3.1.2.4. By Distribution Channel
- 10.3.2. Argentina Eye Drop Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Type
- 10.3.2.2.2. By Drug Class
- 10.3.2.2.3. By Disease Indication
- 10.3.2.2.4. By Distribution Channel
- 10.3.3. Colombia Eye Drop Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Type
- 10.3.3.2.2. By Drug Class
- 10.3.3.2.3. By Disease Indication
- 10.3.3.2.4. By Distribution Channel
- 11. Middle East and Africa Eye Drop Market Outlook
- 11.1. Market Size & Forecast
- 11.1.1. By Value
- 11.2. Market Share & Forecast
- 11.2.1. By Type
- 11.2.2. By Drug Class
- 11.2.3. By Disease Indication
- 11.2.4. By Distribution Channel
- 11.2.5. By Country
- 11.3. MEA: Country Analysis
- 11.3.1. Turkey Eye Drop Market Outlook
- 11.3.1.1. Market Size & Forecast
- 11.3.1.1.1. By Value
- 11.3.1.2. Market Share & Forecast
- 11.3.1.2.1. By Type
- 11.3.1.2.2. By Drug Class
- 11.3.1.2.3. By Disease Indication
- 11.3.1.2.4. By Distribution Channel
- 11.3.2. South Africa Eye Drop Market Outlook
- 11.3.2.1. Market Size & Forecast
- 11.3.2.1.1. By Value
- 11.3.2.2. Market Share & Forecast
- 11.3.2.2.1. By Type
- 11.3.2.2.2. By Drug Class
- 11.3.2.2.3. By Disease Indication
- 11.3.2.2.4. By Distribution Channel
- 11.3.3. Saudi Arabia Eye Drop Market Outlook
- 11.3.3.1. Market Size & Forecast
- 11.3.3.1.1. By Value
- 11.3.3.2. Market Share & Forecast
- 11.3.3.2.1. By Type
- 11.3.3.2.2. By Drug Class
- 11.3.3.2.3. By Disease Indication
- 11.3.3.2.4. By Distribution Channel
- 11.3.4. UAE Eye Drop Market Outlook
- 11.3.4.1. Market Size & Forecast
- 11.3.4.1.1. By Value
- 11.3.4.2. Market Share & Forecast
- 11.3.4.2.1. By Type
- 11.3.4.2.2. By Drug Class
- 11.3.4.2.3. By Disease Indication
- 11.3.4.2.4. By Distribution Channel
- 11.3.5. Kuwait Eye Drop Market Outlook
- 11.3.5.1. Market Size & Forecast
- 11.3.5.1.1. By Value
- 11.3.5.2. Market Share & Forecast
- 11.3.5.2.1. By Type
- 11.3.5.2.2. By Drug Class
- 11.3.5.2.3. By Disease Indication
- 11.3.5.2.4. By Distribution Channel
- 12. Market Dynamics
- 12.1. Drivers
- 12.2. Challenges
- 13. Market Trends & Developments
- 14. Competitive Landscape
- 14.1. Johnson & Johnson Inc.
- 14.2. Genentech, Inc. (Roche)
- 14.3. Alcon Inc.
- 14.4. Pfizer, Inc.
- 14.5. Bausch Health Companies, Inc.
- 14.6. Bayer Corporation
- 14.7. Allergan, Inc. (AbbVie)
- 14.8. Abbott Laboratories Inc.
- 14.9. KC Pharmaceuticals, Inc.
- 14.10. Akorn, Inc.
- 15. Strategic Recommendations
- 16. About Us & Disclaimer
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook